Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.

Allografts Antiemetics / therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects Guideline Adherence Health Care Surveys Hematopoietic Stem Cell Transplantation Humans Italy Myeloablative Agonists / adverse effects Nausea / chemically induced Practice Guidelines as Topic Practice Patterns, Physicians' / statistics & numerical data Transplantation Conditioning / adverse effects Transplantation, Autologous Vomiting / chemically induced
Antiemetic prophylaxis CINV Hematopoietic stem cell transplantation MASCC/ESMO guidelines

Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 08 11 2018
accepted: 27 01 2020
pubmed: 10 2 2020
medline: 10 4 2020
entrez: 10 2 2020
Statut: ppublish

Résumé

A survey within hematopoietic stem cell transplant (HSCT) centers of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) was performed in order to describe current antiemetic prophylaxis in patients undergoing HSCT. The multicenter survey was performed by a questionnaire, covering the main areas on chemotherapy-induced nausea and vomiting (CINV): antiemetic prophylaxis guidelines used, antiemetic prophylaxis in different conditioning regimens, and methods of CINV evaluation. The survey was carried out in November 2016, and it was repeated 6 months after the publication of the Multinational Association of Supportive Care in Cancer (MASCC)/European Society for Medical Oncology (ESMO) specific guidelines on antiemetic prophylaxis in HSCT. The results show a remarkable heterogeneity of prophylaxis among the various centers and a significant difference between the guidelines and the clinical practice. In the main conditioning regimens, the combination of a serotonin

Identifiants

DOI: 10.1007/s00277-020-03945-3 PMID: 32036421
pubmed: 32036421
doi: 10.1007/s00277-020-03945-3
pii: 10.1007/s00277-020-03945-3
doi:

Substances chimiques

Antiemetics 0
Myeloablative Agonists 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

867-875

Auteurs

Domenico Pastore (D)

Hematology, Ospedale A. Perrino, Brindisi, Italy. domenico.pastore0@gmail.com.

Benedetto Bruno (B)

SSCVD Trapianto di Cellule Staminali, AOU Città della Salute e della Scienza di Torino, Turin, Italy.

Paola Carluccio (P)

Department of Emergency and Organ Transplantation, Hematology and Transplantation Unit, Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari, Italy.

Maria Stella De Candia (MS)

Hematology, Ospedale A. Perrino, Brindisi, Italy.

Sonia Mammoliti (S)

National Registry GITMO & Data Managing, Ospedale San Martino, Genova, Italy.

Carlo Borghero (C)

Department of Cellular Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.

Anna Chierichini (A)

Department of Hematology, S. Giovanni Addolorata Hospital, Rome, Italy.

Fabio Pavan (F)

Clinica Pediatrica Ospedale S. Gerardo, Fondazione MBBM, University of Milano-Bicocca, Monza, Italy.

Marco Casini (M)

Hematology Department, San Maurizio Regional Hospital, Bolzano, South Tyrol, Italy.

Massimo Pini (M)

Ematologia, AON SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Luca Nassi (L)

Department of Translational Medicine, Division of Hematology, University of Eastern Piedmont, Novara, Italy.

Raffaella Greco (R)

Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, Italy.

Francesco Paolo Tambaro (FP)

SSD TMO - AORN Santobono-Pausilipon, Naples, Italy.

Paola Stefanoni (P)

Hematology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Giuseppe Console (G)

Hematology and Bone Marrow Transplant Unit, AO BMM, Reggio Calabria, Italy.

Francesco Marchesi (F)

Experimental and Clinical Oncology Department, Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Luca Facchini (L)

Hematology Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy.

Alberto Mussetti (A)

Dipartimento di Ematologia e Onco-Ematologia Pediatrica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Michele Cimminiello (M)

UOC di Ematologia con TMO, Ospedale San Carlo, Potenza, Italy.

Francesco Saglio (F)

Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy.

Daniele Vincenti (D)

U.O.C. Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

Sadia Falcioni (S)

U.O.C. Ematologia e Trapianto di Cellule Staminali Emopoietiche, Ospedale Mazzoni, Ascoli Piceno, Italy.

Patrizia Chiusolo (P)

Istituto di Ematologia, Policlinico Universitario A Gemelli, Università Cattolica, Rome, Italy.

Jacopo Olivieri (J)

UOC Medicina Interna ed Ematologia, ASUR-AV3, Civitanova Marche, Italy.

Annalisa Natale (A)

Department of Hematology, Bone Marrow Transplant Centre, Transfusion Centre and Biotechnology, Ospedale Civile, Pescara, Italy.

Maura Faraci (M)

Hematopoetic Stem Cell Transplant Unit, Hematology-Oncology, G. Gaslini Institute, Genoa, Italy.

Simone Cesaro (S)

Department of Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Policlinico G.B. Rossi, Verona, Italy.

Serena Marotta (S)

Department of Clinical Medicine and Surgery, Hematology, Federico II University, Naples, Italy.

Anna Proia (A)

Unit of Hematology and Stem Cell Transplant, Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy.

Irene Donnini (I)

SODc Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy.

Daniela Caravelli (D)

Medical Oncology, Hematopoietic Stem Cells Unit, Turin Metropolitan Transplant Centre, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.

Eliana Zuffa (E)

Unitá Operativa di Ematologia, Ravenna, Italy.

Anna Paola Iori (AP)

Department of Hematology, Azienda Policlinico Umberto I, Sapienza University of Roma, Rome, Italy.

Elena Soncini (E)

Pediatric Hematology-Oncology, BMT Unit, Spedali Civili, Brescia, Italy.

Valentina Bozzoli (V)

Divisione di Ematologia, Ospedale di Lecce, Lecce, Italy.

Giovanni Pisapia (G)

Hematology Unit and BMT, Department of Oncology, San Giuseppe Moscati Hospital, Taranto, Italy.

Renato Scalone (R)

Dipartimento Oncologico "La Maddalena", UOC di Oncoematologia e TMO, Palermo, Italy.

Oreste Villani (O)

Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture, Potenza, Italy.

Arcangelo Prete (A)

Oncology, Hematology and Hematopoietic Stem Cell Transplant Program, U.O. Pediatrics-S. Orsola-Malpighi, University of Bologna, Bologna, Italy.

Antonella Ferrari (A)

Haematology Unit, AOU Sant'Andrea, Rome, Italy.

Mariacristina Menconi (M)

Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Giorgia Mancini (G)

Division of Hematology, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy.

Federica Gigli (F)

Hematology, Istituto Europeo di Oncologia, Milan, Italy.

Gianpaolo Gargiulo (G)

UOC Hematology and TCSE, AOU Federico II, Naples, Italy.

Barbara Bruno (B)

National Registry GITMO & Data Managing, Ospedale San Martino, Genova, Italy.

Francesca Patriarca (F)

Department of Hematology, DAME, University of Udine, Udine, Italy.

Francesca Bonifazi (F)

Unit of Hematology and Medical Oncology, "L. and A. Seragnoli", St. Orsola-Malpighi Polyclinic, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions du corps › Transplants › Allogreffes › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents gastro-intestinaux › Antiémétiques › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Protocoles de polychimiothérapie antinéoplasique › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Adhésion aux directives › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes sur les soins de santé › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Régions géographiques › Europe › Italie › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Agonistes myélo-ablatifs › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes digestifs › Nausée › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Types de pratiques des médecins › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunosuppression thérapeutique › Conditionnement pour greffe › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation autologue › Antiemetic prophylaxis in patients undergoing...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes digestifs › Vomissement › Antiemetic prophylaxis in patients undergoing...